A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective-Reference-Cited by-同舟云学术

A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

Published:2020-01-30 Issue:3 Volume:13 Page:317-325
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Louis Edouard,Ramos-Goñi Juan M.,Cuervo Jesus,Kopylov Uri,Barreiro-de Acosta Manuel,McCartney Sara,Rosenfeld Greg^ORCID,Bettenworth Dominik^ORCID,Hart Ailsa,Novak Kerri,Donnet Xavier,Easton David,Saldaña Roberto,Protze Katja,Tzur Eyal,Alperovich Gabriela,Casellas Francesc

Funder

AbbVie

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40271-019-00407-5.pdf

Reference24 articles.

1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–605.

2. Cosnes J, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–94.

3. Kumar V, Abbas AK, Fousto N, Robbins SL, Cotran RS. Robbins and Cotran pathologic basis of disease. 9th ed. Philadelphia, PA: Saunders Elsevier; 2015.

4. Ng SC, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–78.

5. Conway G, et al. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45(6):814–23.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR);Digestive and Liver Disease;2024-09

2. Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease;International Journal of Environmental Research and Public Health;2024-08-28

3. The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease—A Real-World Study;Drugs - Real World Outcomes;2024-06-15

4. Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment;Inflammatory Bowel Diseases;2024-03-20

5. Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study;Inflammatory Bowel Diseases;2024-03-09